Researchers are evaluating whether biologic therapies for severe asthma reduce the risk for osteoarthritis progression in ...

One cause of apparently resistant asthma is ‘wrong diagnosis’ – what are the differentials we should be aware of, and how can we distinguish them from true asthma? Resistant asthma is asthma that ...

Nonclinical factors are more likely to drive discontinuation of biologic therapy for patients with severe asthma.

Opportunities in the asthma market include the growth driven by innovative therapies like dexpramipexole and depemokimab, expanding patient pools due to rising asthma prevalence, and increased ...

As the Middle East war continues to rage on, many Americans are growing anxious that the military will institute a draft call ...

We recently compiled a list of the 11 Best Kid-Friendly Stocks to Invest In. Amgen Inc. (NASDAQ:AMGN) is one of the best kid-friendly stocks on our list. On March 3, TheFly reported that Kyowa Kirin ...

Public health physicians in B.C. are calling for an independent assessment of health impacts from the oil and gas industry.

The government knew a harmful toxin had been found in its algal bloom, but took months to update its health advice.

Israel bombed oil depots in Tehran, leading to thick toxic smoke and acid rain falling over the capital's nine million people ...

To inform clinicians on the best biologic agent for different populations of adults with severe asthma, 12 experts collaborated on a new clinical practice guideline published in CHEST, according to a ...

There are similarities in airway inflammatory endotype between eosinophilic granulomatosis with polyangiitis (EGPA) and type 2 eosinophilic asthma. Here, the authors perform single-cell ...

Among seven new medicines recommended for approval by the EMA's human medicine advisory committee at its latest meeting is GSK's depemokimab, a long-acting anti-IL-5 antibody for severe asthma and an ...